As of 2025-09-15, the Relative Valuation of Syndax Pharmaceuticals Inc (SNDX) is (57.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.55 USD, the upside of Syndax Pharmaceuticals Inc based on Relative Valuation is -467.6%.
The range of the Relative Valuation is (54.99) - (69.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 17.8x | 14.7x |
| Forward P/E multiples | 14.1x - 20.8x | 14.7x |
| Fair Price | (54.99) - (69.30) | (57.17) |
| Upside | -453.6% - -545.7% | -467.6% |
| Date | P/E |
| 2025-09-12 | -4.00 |
| 2025-09-11 | -4.21 |
| 2025-09-10 | -4.04 |
| 2025-09-09 | -4.10 |
| 2025-09-08 | -4.20 |
| 2025-09-05 | -4.38 |
| 2025-09-04 | -4.16 |
| 2025-09-03 | -4.15 |
| 2025-09-02 | -4.15 |
| 2025-08-29 | -4.20 |
| 2025-08-28 | -4.20 |
| 2025-08-27 | -4.18 |
| 2025-08-26 | -4.08 |
| 2025-08-25 | -4.03 |
| 2025-08-22 | -4.18 |
| 2025-08-21 | -4.07 |
| 2025-08-20 | -4.05 |
| 2025-08-19 | -3.96 |
| 2025-08-18 | -4.08 |
| 2025-08-15 | -4.05 |
| 2025-08-14 | -3.79 |
| 2025-08-13 | -3.46 |
| 2025-08-12 | -3.34 |
| 2025-08-11 | -3.22 |
| 2025-08-08 | -3.21 |
| 2025-08-07 | -3.27 |
| 2025-08-06 | -3.31 |
| 2025-08-05 | -3.23 |
| 2025-08-04 | -2.67 |
| 2025-08-01 | -2.57 |
| 2025-07-31 | -2.55 |
| 2025-07-30 | -2.57 |
| 2025-07-29 | -2.66 |
| 2025-07-28 | -2.46 |
| 2025-07-25 | -2.48 |
| 2025-07-24 | -2.57 |
| 2025-07-23 | -2.63 |
| 2025-07-22 | -2.65 |
| 2025-07-21 | -2.50 |
| 2025-07-18 | -2.43 |
| 2025-07-17 | -2.49 |
| 2025-07-16 | -2.38 |
| 2025-07-15 | -2.37 |
| 2025-07-14 | -2.53 |
| 2025-07-11 | -2.47 |
| 2025-07-10 | -2.53 |
| 2025-07-09 | -2.38 |
| 2025-07-08 | -2.25 |
| 2025-07-07 | -2.24 |
| 2025-07-03 | -2.31 |